PRKCI promotes immune suppression in ovarian cancerSharmistha Sarkar, Lynda Chin, Christopher A. Bristow et al.|Genes & Development|2017Cited by 100
Mutant <i>KRAS</i> Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer MonitoringRuth Perets, Dov Hershkovitz, Orli Greenberg et al.|The Oncologist|2018Cited by 96
Abstract CT022: Divarasib plus migoprotafib combination treatment in patients with <i>KRAS G12C</i>-positive non-small cell lung cancer (NSCLC)Jia Luo, Myung‐Ju Ahn, Rafał Dziadziuszko et al.|Cancer Research|2025Cited by 2